ODM-212

· Orion Corporation / Orion Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ODM-212, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours [Phase 1, Phase 2]